Vimarsana
Biggest News Aggregation in the World

Regulatory Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulatory Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulatory Factor Today - Breaking & Trending Today

The effects of vitamin K on bone health - Vimarsana News

The effects of vitamin K on bone health

Existing scientific data on the effects of vitamin K (VK) on bone health and elucidated the underlying mechanisms.

Traditional vs digital bank: Survival of the fittest - Vimarsana News

Traditional vs digital bank: Survival of the fittest

By investing in cutting-edge technology and streamlining their operations, traditional banks can upgrade conventional banking to bring it at par with the digital banking The financial world is undergoing a seismic shift as traditional banks and digital banks engage in an epic battle for supremacy.

Cannabis Stocks Resurge: Regulatory Optimism Sparks Green Wave - Vimarsana News

Cannabis Stocks Resurge: Regulatory Optimism Sparks Green Wave

Cannabis stocks make a comeback as regulatory changes bring hope. Explore the ups and downs of the cannabis market and top-performing companies.

Frontiers | Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1 - Vimarsana News

Frontiers | Notch2 Increases the Resistance to Venetoclax-Induced Apoptosis in Chronic Lymphocytic Leukemia B Cells by Inducing Mcl-1

Chronic lymphocytic leukemia (CLL) has experienced a clinical revolution thanks to the discovery of crucial pathogenetic mechanisms. CLL is still an incurable disease due to intrinsic or acquired resistance of the leukemic clone. Venetoclax is a Bcl-2 inhibitor with a marked activity in CLL, but emerging patterns of resistance are being described. We hypothesize that intrinsic features of CLL cells may contribute to drive mechanisms of resistance to venetoclax. We analyzed the expression of IRF4, Notch2 and Mcl-1 in a cohort of CLL patients. We evaluated CLL cells viability after genetic and p...